妊娠35-37周联合筛查子痫前期后的拟议临床管理
这项前瞻性观察研究纳入3703例单胎妊娠,在35-37周联合母体特征、MAP、UtA-PI、PlGF和sFlt-1计算子痫前期风险并分层。高危组涵盖92%的<40周子痫前期和73%的≥40周子痫前期,低危组无子痫前期发生。
要点
- 35-37周联合筛查可将孕妇分为高危、中危、低危三层管理。
- 高危组含92%的<40周子痫前期,低危组无子痫前期发生。
- 中危组需在40周再评估,高危组需从初评起加强监测至40周。
核心结论
- 35-37周联合筛查可将子痫前期风险分层,高危组需从初评起加强监测至40周,中危组需40周再评估,低危组可安慰其子痫前期可能性低。
研究设计与样本
- 前瞻性观察研究,纳入3703例单胎妊娠,在35-37周常规孕检时行超声筛查,采用竞争风险模型结合母体特征与MAP、UtA-PI、PlGF、sFlt-1的MoM值计算风险。
诊断标准与关键数值
- 高危组定义为评估后4周内分娩子痫前期风险≥1/50,低危组定义为<42周分娩子痫前期风险<1/100,其余为中危组。
临床应用与阅片要点
- 高危组占12.7%,含92%的<40周子痫前期和73%的≥40周子痫前期;中危组占28.8%,另含27%的≥40周子痫前期;低危组占58.5%,无<40周或≥40周子痫前期发生。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To estimate the patient-specific risk of pre-eclampsia (PE) at 35-37 weeks' gestation by a combination of maternal characteristics and medical history with multiples of the median (MoM) values of mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), serum placental growth factor (PlGF) and serum soluble fms-like tyrosine kinase-1 (sFlt-1), and stratify women into high-, intermediate- and low-risk management groups.
METHODS: This was a prospective observational study in women attending a third-trimester ultrasound scan at 35-37 weeks as part of routine pregnancy care. Patient-specific risks of delivery with PE at < 4 weeks from assessment and PE at < 42 weeks' gestation were calculated using the competing-risks model to combine the prior risk from maternal characteristics and medical history with MoM values of MAP, UtA-PI, PlGF and sFlt-1. On the basis of these risks, the population was stratified into high-, intermediate- and low-risk groups. Different risk cut-offs were used to vary the proportion of the population stratified into each risk category and the performance of screening for delivery with PE at < 40 and ≥ 40 weeks' gestation was estimated.
RESULTS: The study population of 3703 singleton pregnancies included 38 (1.0%) with PE < 40 weeks' gestation and 22 (0.6%) with PE ≥ 40 weeks. Using a risk cut-off of 1 in 50 for PE delivering at < 4 weeks after assessment to define the high-risk group and a risk cut-off of < 1 in 100 for PE delivering at < 42 weeks' gestation to define the low-risk group, the proportion of the population stratified into high, intermediate and low risk was 12.7%, 28.8% and 58.5%, respectively. The high-risk group contained 92% of pregnancies with PE at < 40 weeks' gestation and 73% of those with PE at ≥ 40 weeks. The intermediate-risk group contained a further 27% of women with PE at ≥ 40 weeks. In the low-risk group, none of the women developed PE at < 40 or ≥ 40 weeks' gestation.
CONCLUSION: The study presents risk stratification of PE by the combined test at 35-37 weeks, aiming to identify a high-risk group in need of intensive monitoring from the time of the initial assessment and up to 40 weeks' gestation, an intermediate-risk group in need of reassessment at 40 weeks' gestation and a low-risk group that can be reassured that they are unlikely to develop PE. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Panaitescu AM, Wright D, Militello A, et al. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol. 2017. PMID: 28133834. doi:10.1002/uog.17419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。